Mirjam Groger

Universität Hamburg — Germany

Medicine · Health Sciences

16h-index776citations43works2.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Malaria Research and Control(14), Viral Infections and Outbreaks Research(13), Disaster Response and Management(7), Mosquito-borne diseases and control(5), Hepatitis B Virus Studies(5)

Publications43 total

Safety and tolerability of dexamethasone combined with standard-of-care Ribavirin for the treatment of Lassa fever: An open-label randomized controlled phase II clinical trial
Journal of Interventional Epidemiology and Public Health·2025Open Access
Safety and tolerability of Favipiravir compared to Ribavirin for the treatment of Lassa fever: A randomized controlled open-label phase II clinical trial
Journal of Interventional Epidemiology and Public Health·2025Open Access
Electrocardiographic alterations in patients treated for acute Lassa Fever: Description of results from a phase II clinical trial in Nigeria
Journal of Infection and Public Health·2025· 3 citedOpen Access
Genetic diversity of Plasmodium malariae in sub-Saharan Africa: a two-marker genotyping approach for molecular epidemiological studies
Frontiers in Cellular and Infection Microbiology·2024· 1 citedOpen Access
Plasmodium ovale spp dhfr mutations associated with reduced susceptibility to pyrimethamine in sub-Saharan Africa: a retrospective genetic epidemiology and functional study
The Lancet Microbe·2024· 5 citedOpen Access
Rapid diagnostic tests for Lassa fever: what do we aim for?
The Lancet Infectious Diseases·2024· 4 cited
Lack of Suspicion of Dapsone Hypersensitivity Syndrome in a Leprosy Patient: Case Report with Fatal Outcome
Research and Reports in Tropical Medicine·2023· 2 citedOpen Access
OA-652 Safety and tolerability of favipiravir for the treatment of Lassa fever: a randomized controlled open label phase II clinical trial
2023· 2 citedOpen Access
PA-424 The INTEGRATE study: an adaptive platform trial for the development of new interventions to combat Lassa Fever in West Africa
2023Open Access
Community health workers in clinical research at the example of a phase IIIb/ IV antimalarial drug trial conducted in five African countries
International Journal of Infectious Diseases·2023· 1 citedOpen Access
Neuevaluierung der Ribavirintherapie bei Lassafieber
Flugmedizin · Tropenmedizin · Reisemedizin - FTR·2022
Two Cases of Lassa Fever Successfully Treated with Ribavirin and Adjunct Dexamethasone for Concomitant Infections
Emerging infectious diseases·2022· 6 citedOpen Access
Pharmacokinetics of Ribavirin in the Treatment of Lassa Fever: An Observational Clinical Study at the Irrua Specialist Teaching Hospital, Edo State, Nigeria
Clinical Infectious Diseases·2022· 13 citedOpen Access
Effectiveness of pyronaridine-artesunate against Plasmodium malariae, Plasmodium ovale spp, and mixed-Plasmodium infections: a post-hoc analysis of the CANTAM-Pyramax trial
The Lancet Microbe·2022· 11 citedOpen Access
Challenges in the clinical development pathway for triple and multiple drug combinations in the treatment of uncomplicated falciparum malaria
Malaria Journal·2022· 19 citedOpen Access
Diagnostic performance of capillary and venous blood samples in the detection of Loa loa and Mansonella perstans microfilaraemia using light microscopy
PLoS neglected tropical diseases·2021· 19 citedOpen Access
Pyronaridine–artesunate real-world safety, tolerability, and effectiveness in malaria patients in 5 African countries: A single-arm, open-label, cohort event monitoring study
PLoS Medicine·2021· 46 citedOpen Access
More than 80 %  of sequentially bilaterally implanted CI-patients are not treated sufficiently during the bimodal phase
Laryngo-Rhino-Otologie·2021Open Access
Über 80 %  der sequentiell-bilateral implantierten CI-Patienten sind in der bimodalen Phase nicht ausreichend versorgt.
Laryngo-Rhino-Otologie·2021Open Access
Low-cost CI-Elektroden- und Cochleadummiesfür minimal-invasive Insertionsübungen
Laryngo-Rhino-Otologie·2021Open Access
page 1 of 3Next →

Frequent Co-authors

Michael Ramharter(36), Ghyslain Mombo‐Ngoma(19), Ayôla Akim Adégnika(14), Johannes Mischlinger(12), Sélidji Todagbé Agnandji(12), Luzia Veletzky(11), Peter G. Kremsner(11), Felix Lötsch(10), Stephan Günther(9), Benjamin Mordmüller(7), Osahogie Isaac Edeawe(7), Sylvanus Okogbenin(7), Cyril Erameh(7), Bertrand Lell(6), Peter Akhideno(6), Meike Pahlmann(6), Rella Zoleko Manego(5), Rella Zoleko‐Manego(5), Herbert Auer(5), Albert Lalremruata(4)